Advances in Molecular and Genetic Biomarkers in Head and Neck Squamous Cell Carcinoma
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: 24 June 2025 | Viewed by 33
Special Issue Editors
Interests: molecular biology; genetics; epigenetics, head and neck cancers
Special Issues, Collections and Topics in MDPI journals
2. Department of Head and Neck Surgery, Poznan University of Medical Sciences, Poznan, Poland
Interests: head and neck cancer; biomarkers; miRNA; cell biology; cellular senescence; animal physiology; insulin signaling; aging; molecular biology; metabolism
Special Issue Information
Dear Colleagues,
Head and Neck Squamous Cell Carcinoma (HNSCC) remains a significant oncological challenge due to its heterogeneity and complex molecular landscape. While research has identified diverse subtypes and neoplastic pathways in HNSCC, there's a critical need for specific and translatable molecular biomarkers for screening and diagnosis.
Recent advancements in analyzing DNA, RNA, and proteins offer unprecedented insights into HNSCC's molecular underpinnings. Identifying novel biomarkers associated with cancer development and progression is crucial for early detection and improved patient outcomes.
This special issue delves into the latest advancements in molecular and genetic biomarkers for HNSCC. We welcome high-quality original research and reviews focusing on multi-omics approaches (genomics, transcriptomics, proteomics) to unravel the fundamental mechanisms of HNSCC carcinogenesis, specially that explore novel biomarkers for early detection, risk stratification, and potential therapeutic targets.
By fostering research in these areas, this special issue aims to improve our understanding of HNSCC and pave the way for more precise diagnosis, risk assessment, and targeted therapies.
We look forward to receiving your contributions.
Prof. Dr. Joanna Katarzyna Strzelczyk
Prof. Dr. Michal Masternak
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- head and neck squamous cell carcinoma (HNSCC)
- molecular biomarkers
- genetic biomarkers
- multi-omics approaches
- HNSCC carcinogenesis
- prognostic biomarkers
- translational medicine
- molecular pathology
